Human Amniotic Fluid
Identification
- Generic Name
- Human Amniotic Fluid
- DrugBank Accession Number
- DB15871
- Background
Human amniotic fluid is the liquid surrounding the human embryo and fetus.1 Physically, the fluid provides protection through cushioning. Chemically, the fluid provides protection through its inherent antibacterial properties. The fluid contains carbohydrates, proteins, lipids, electrolytes, urea, immunoglobulins, growth factors, and vitamins.1,2
- Type
- Biotech
- Groups
- Investigational
- Synonyms
- Not Available
- External IDs
- Human Amniotic Fluid
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Human amniotic fluid was seen to reduce inflammation in lungs of COVID-19 patients through a decrease in C-reactive protein in a study.2 However, the mechanisms of action of this therapy are unclear. Currently, human amniotic fluid is being investigated against COVID-19.
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 6SQ06FQ2GH
- CAS number
- Not Available
References
- General References
- External Links
- Not Available
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 2 Recruiting Treatment Venous Leg Ulcers (VLU) / Venous Stasis Ulcers (VSU) 1 1, 2 Completed Treatment Coronavirus Disease 2019 (COVID‑19) 2 1, 2 Recruiting Treatment Osteoarthritis of the Knee 1 0 Completed Treatment Coronavirus Disease 2019 (COVID‑19) 1 Not Available Unknown Status Treatment Fatty Atrophy / Rotator Cuff Tears 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at September 21, 2020 17:22 / Updated at September 22, 2020 13:00